Gilead Sciences (GILD): Harvoni, Sovaldi TRx Up Week-over-Week - Leerink

November 25, 2016 7:28 AM EST
Get Alerts GILD Hot Sheet
Price: $72.37 -0.07%

Rating Summary:
    24 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade GILD Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

IMS data showed Gilead Sciences (NASDAQ: GILD) showed Harvoni scripts were up week-over-week and Sovaldi prescriptions were up, Leerink Parnters notes.

The firm commented, "Harvoni TRx for the week were 4,428 (1,778 were NRx), representing a 7.1% increase in TRx and a 9.6% increase in NRx w/w, after a 1.1% increase in TRx and a 1.0% decrease in NRx last week. Sovaldi TRx for the week were 466 (114 were NRx), representing a 2.6% increase in TRx and a 9.6% increase in NRx w/w, after a 17.0% decrease in TRx and an 18.8% decrease in NRx last week."



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, FDA

Add Your Comment